Sana Biotechnology Inc vs Stanley Black & Decker, Inc. — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Stanley Black & Decker, Inc. trades at $87.62 (market cap $13.60B). The key difference: Stanley Black & Decker, Inc. is far larger — about 15.6× Sana Biotechnology Inc's market cap, and Stanley Black & Decker, Inc. pays a 3.79% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| SANA | SWK | |
|---|---|---|
Market Cap | $873.84M | $13.60B |
Sector | Health | — |
52-Week High | $5.92 | $94.12 |
52-Week Low | $2.68 | $62.12 |
Enterprise Value | $848.03M | $19.77B |
Dividend Yield | — | 3.79% |
Trailing returns across standard periods
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →